Mango supplementation modulates gut microbial dysbiosis and short-chain fatty acid production independent of body weight Reduction in C57BL/6mice fed a high-fat diet

Journal of Nutrition

Volumn 146, Issue 8, 2016, Pages 1483-1491

  Ojo, Babajide ^a   El Rassi, Guadalupe Davila ^a   Payton, Mark E ^a   Perkins Veazie, Penelope ^b   Clarke, Stephen ^a   Smith, Brenda J ^a   Lucas, Edralin A ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Glucose; Gut inflammation; Gut microbiota; High fat diet; Lipids; Mango; Short chain fatty acid

Indexed keywords

ACETIC ACID; DNA 16S; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 43; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOVALERIC ACID; PROPIONIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; VALERIC ACID; MESSENGER RNA; PLANT MEDICINAL PRODUCT; VOLATILE FATTY ACID;

AKKERMANSIA MUCINIPHILA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BODY FAT; BODY WEIGHT; CALORIC INTAKE; CECUM; COLON; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DNA SEQUENCE; DYSBIOSIS; FASTING BLOOD GLUCOSE; FAT MASS; FATTY ACID BLOOD LEVEL; FERMENTATION; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; ILEUM; INTESTINE FLORA; LAMINA PROPRIA; LIPID DIET; MALE; MANGO; MICROBIOME; MOUSE; NONHUMAN; ORGAN WEIGHT; PARABACTEROIDES; RUMINOCOCCUS; WEIGHT REDUCTION; ADVERSE EFFECTS; ANIMAL; BACTERIUM; C57BL MOUSE; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; FRUIT; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; LARGE INTESTINE; MANGIFERA; METABOLISM; MICROBIOLOGY; OBESITY; PATHOLOGY;

ANIMALS; BACTERIA; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DYSBIOSIS; FATTY ACIDS, VOLATILE; FRUIT; GASTROINTESTINAL MICROBIOME; INFLAMMATION; INTERLEUKIN-10; INTESTINE, LARGE; MALE; MANGIFERA; MICE, INBRED C57BL; OBESITY; PLANT PREPARATIONS; RNA, MESSENGER; WEIGHT LOSS;

EID: 84980416285     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.226688     Document Type: Article

References (46)

1. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012;9: 577-89.
2. Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012;3:4-14.
3. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemiainduced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
4. Gibson GR, Beatty ER,Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-82.
5. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 2007;10: 729-34.
6. Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van Holle A, Muccioli GG, Deldicque L, Bindels LB, Pachikian BD, Sohet FM. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARg-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 2011;22:712-22.
7. Cani PD, Delzenne NM. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner. Acta Gastroenterol Belg 2010; 73:267-9.
8. Bauer E, Williams BA, Smidt H, Mosenthin R, Verstegen MW. Influence of dietary components on development of the microbiota in singlestomached species. Nutr Res Rev 2006;19:63-78.
9. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
10. Fung KY, Cosgrove L, Lockett T, Head R, Topping DL. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 2012;108:820-31.
11. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504:451-5.
12. Lin HV, Frassetto A, Kowalik EJ, Jr., Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012;7: e35240.
13. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003;278:11312-9.
14. Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 2008;56:305-9.
15. Shah KA, Patel M, Patel R, Parmar P. Mangifera indica (mango). Pharmacogn Rev 2010;4:42-8.
16. Masibo M, He Q. Mango bioactive compounds and related nutraceutical properties: a review. Food Rev Int 2009;25:346-70.
17. Ramulu P, Rao PU. Total, insoluble and soluble dietary fiber contents of Indian fruits. J Food Compos Anal 2003;16:677-85.
18. Taing M-W, Pierson J-T, Hoang VL, Shaw PN, Dietzgen RG, Gidley MJ, Roberts-Thomson SJ, Monteith GR. Mango fruit peel and flesh extracts affect adipogenesis in 3T3-L1 cells. Food Funct 2012;3:828-36.
19. Noratto GD, Bertoldi MC, Krenek K, Talcott ST, Stringheta PC, Mertens-Talcott SU. Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties. J Agric Food Chem 2010;58: 4104-12.
20. Lucas EA, Li W, Peterson SK, Brown A, Kuvibidila S, Perkins-Veazie P, Clarke SL, Smith BJ. Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet. Br J Nutr 2011;106:1495-505.
21. Evans SF, Meister M, Mahmood M, Eldoumi H, Peterson S, Perkins- Veazie P, Clarke SL, Payton M, Smith BJ, Lucas EA. Mango supplementation improves blood glucose in obese individuals. Nutr Metab Insights 2014;7:77-84.
22. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013;10:996-8.
23. Zhao G, Nyman M, Åke Jönsson J. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed Chromatogr 2006;20:674-82.
24. Valasek MA, Clarke SL, Repa JJ. Fenofibrate reduces intestinal cholesterol absorption via PPARa-dependent modulation of NPC1L1 expression in mouse. J Lipid Res 2007;48:2725-35.
25. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101-8.
26. Houser B. Bio-Rad's Bio-Plex® suspension array system, xMAP technology overview. Arch Physiol Biochem 2012;118:192-6.
27. Carr TP, Andresen CJ, Rudel LL. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 1993;26:39-42.
28. Folch J, Lees M, Stanley G. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226: 497-509.
29. Bruin JE, Gerstein HC, Morrison KM, Holloway AC. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Toxicol Sci 2008;103: 362-70.
30. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 2014; 15:550.
31. McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013;8:e61217.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol 1995;57:289-300.
33. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010;18:190-5.
34. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Ca Z, Li L, Zhou A. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010;61:69-78.
35. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls dietinduced obesity. Proc Natl Acad Sci USA 2013;110:9066-71.
36. Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int J Syst Evol Microbiol 2008;58:1221-7.
37. Berardini N, Fezer R, Conrad J, Beifuss U, Carle R, Schieber A. Screening of mango (Mangifera indica L.) cultivars for their contents of flavonol O-and xanthone C-glycosides, anthocyanins, and pectin. J Agric Food Chem 2005;53:1563-70.
38. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012;6:1535-43.
39. Parnell JA, Reimer RA. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. Br J Nutr 2012;107:601-13.
40. Urías-Silvas JE, Cani PD, Delmée E, Neyrinck A, López MG, Delzenne NM. Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr 2008; 99:254-61.
41. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008;83:460-9.
42. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29:71-109.
43. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest 2007;117:143-52.
44. Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. Am J Physiol Endocrinol Metab 2003;284:E931-9.
45. Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006;55:1484-90.
46. Pederson RA, SatkunarajahM,McIntosh C, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor2/2 mice. Diabetes 1998;47:1046-52.